NCT00998881View on ClinicalTrials.gov

Monotherapy Study of MP-513 in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

203

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Teneligliptin 20 mg

DRUG

Placebo

Trial Locations (1)

Unknown

Sapporo

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY